VOLUME
Sell
TREND
Buy
MV LONG
Sell

MV SHORT
Sell

PIVOT
Buy

MACD
Buy

PETX Forecast and Technical Stock Analysis

PDF
Buy candidate since 2019-08-13

No changes to the price of Aratana Therapeutics in the last trading day ( Monday, 19th Aug 2019 ). During the day the stock fluctuated 0.00% from a day low at $4.92 to a day high of $4.92. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

Quick summary:

  • 30 day high of the PETX stock price was $4.92 and low was $4.92.
  • 90 day high was $5.30 and low was $4.59.
  • 52 week high for Aratana Therapeutics - $7.16 and low - $3.30.
Top Trending Stocks

Trend

Aratana Therapeutics lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 2.96% during the next 3 months and, with 90% probability hold a price between $4.90 and $5.48 at the end of this period.

Top Golden Star Stocks

Signals

Aratana Therapeutics holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $4.92 and $4.97. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued. Some positive signals were issued as well, and these may have some influence on the near short-term development. A buy signal was issued from a pivot bottom point on Wednesday July 17, 2019, which indicates further gains until a new top pivot has been found.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSImin/max Values: [ 25 - 75 ]

RSI14 is 50 and the stock is currently not being overbought or oversold

* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.

Support & Resistance

Aratana Therapeutics finds support from accumulated volume at $4.87.

Support: $4.87 Price: $4.92 Resistance: $4.93

Risk

This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.00 between high and low, or 0.00%. For the last week the stock has had a daily average volatility of 0.00%.

Our recommended stop-loss: $4.62 (-6.00%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from pivot bottom found 23 days ago.)

0.00 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Buy Candidate Upgraded

Evaluation

Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, for the wholesome period, we think that today's level holds a possible buying-opportunity and that the price will be higher during or at the end of this 3-month period.

Will PETX stock price go up or down on Wed, 21 Aug 2019?

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
Trading With Moving Average
As an investor, you always seek to understand what other... Full Article
Pivot Points
Pivot Points refer to points of significant change. As a... Full Article
Accumulated Volume - Support and Resistance
Volume is perhaps the best indicator of all and should... Full Article
Volume - The Indicator You Really Need to Know
Many new traders getting into the world of technical analysis... Full Article
We Give Back!
In 2016 StockInvest.us donated to NGO Goodwill projects to help purchase medical... Full Article
Better Buy: Amazon vs. Facebook
Amazon's stock slipped 21% over the past six months, as... Full Article

Proudly made at

ROCKIT